Brief: Altamira Therapeutics Prospectus Relates To Disposition Of Up To 5.9 Mln Shares
01/06/2023 23:11
June 1 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS LTD - PROSPECTUS RELATES TO
DISPOSITION
FROM TIME TO TIME OF UP TO 5.9 MILLION COMMON SHARES BY SELLING
STOCKHOLDERS- SEC FILING
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering